Pulmonx Corp
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $90.5M | $83.8M | $68.7M | $53.7M | $48.4M |
| Gross profit | $67.1M | $62.0M | $50.8M | $39.9M | $35.6M |
| Operating income | -$53.7M | -$57.7M | -$61.9M | -$58.6M | -$47.3M |
| Operating expenses | $120.8M | $119.7M | $112.7M | $98.5M | $82.9M |
| Cost of revenue | $23.4M | $21.8M | $17.9M | $13.8M | $12.8M |
| Cash from operations | -$32.4M | -$31.5M | -$37.6M | -$45.1M | -$41.4M |
| Capital expenditure | $452,000 | $1.4M | $807,000 | $1.3M | $3.7M |
| Free cash flow | -$32.8M | -$33.0M | -$38.4M | -$46.4M | -$45.1M |
| Share repurchases | — | — | $0 | $27,000 | $26,000 |
| Total assets | $129.3M | $162.8M | $177.8M | $193.7M | $235.2M |
| Total liabilities | $75.2M | $77.0M | $59.5M | $39.7M | $41.9M |
| Total debt | $42.5M | — | $45.7M | $22.3M | $19.1M |
Shares outstanding 42.2M · Free float 85.7%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.